Renewing Hemgenix Coverage with Blue Cross Blue Shield in California: Annual Requirements and Timeline
Answer Box: Blue Shield of California requires annual reauthorization for Hemgenix (etranacogene dezaparvovec) gene therapy. Start renewal 60-90 days before your authorization expires. Submit updated clinical documentation showing ongoing eligibility, Factor IX levels, bleeding episodes, liver function tests, and provider attestation through Blue Shield's AuthAccel portal or designated